Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMARIN CORP PLC\UK files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
130
181
229
430
614
583
369
307
229
214
Cost of revenue
34.4
45
54.5
96
131
121
Gross profit
95.7
136
175
334
483
462
242
166
81.4
121
Research and development
50
47.2
55.9
34.4
39
29.3
30.4
22.2
20.9
19.8
Selling, general and administrative
111
135
227
324
463
408
304
200
152
115
General and administrative
75.3
52.6
38.3
43.8
Operating expenses
161
182
283
358
502
451
348
233
173
171
Operating income
-65.6
-45.6
-108
-24.3
-19.7
10.5
-106
-67.6
-91.8
-50.2
Interest expense
18.7
9.77
8.87
6.63
2.61
0.13
0.02
0.01
0.01
0.01
Interest income
0.23
0.43
1.07
8.5
4.9
1.22
2.82
11.9
13.4
10.9
Other non-operating income
-0.48
0.07
-0.33
-0.08
0.1
-0.3
-0.74
2.06
1.2
3.28
Pre-tax income
-76.4
-54.8
-116
-22.5
-17.3
11.3
-104
-53.7
-77.2
-36
Income tax
9.97
13
0.1
0.16
0.75
3.56
2
5.44
4.98
2.75
Net income
-86.4
-67.9
-116
-22.6
-18
7.73
-106
-59.1
-82.2
-38.8
EBITDA
-65.5
-45.5
-108
-24.1
-19.1
11.1
-105
-67.4
-91.7
EPS, basic
-0.41
-0.25
-0.39
-0.07
-0.05
0.02
-0.26
-0.15
-0.20
-0.09
EPS, diluted
-0.41
-0.25
-0.39
-0.07
-0.05
0.02
-0.26
-0.15
-0.20
-0.09
Shares, basic (weighted)
212
271
297
343
382
396
401
408
411
415
Shares, diluted (weighted)
212
271
297
343
382
402
401
408
411
415
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
98.3
73.6
249
645
187
219
218
199
121
135
Short-term investments
314
235
91.7
121
173
168
Receivables
20
45.3
66.5
116
155
164
131
134
122
127
Inventory
20.5
30.3
57.8
76.8
189
235
229
259
166
196
Other current assets
6.98
3.46
2.95
13.3
30.9
22.4
19.5
11.6
12.6
24.4
Total current assets
146
153
378
855
879
879
689
725
595
650
Property, plant and equipment
0.08
0.03
0.06
2.36
2.02
1.43
0.87
0.11
0.02
0.01
Lease right-of-use assets
8.51
8.05
7.66
9.07
8.31
7.59
6.46
Intangible assets
8.77
8.13
7.48
15.3
13.8
23.5
21.8
19.3
16.4
13.4
Long-term investments
62.5
35
1.28
Other non-current assets
0.74
0.17
0.17
1.07
0.43
0.46
0.46
1.36
1.21
1.07
Total assets
167
162
386
882
966
1,068
886
832
685
671
Accounts payable
6.06
25.2
37.6
50
106
115
64.6
52.8
40.4
45.4
Accrued liabilities
6.61
8.3
12.2
21.2
22.8
19.7
20.3
18.9
15.4
11.3
Deferred revenue
1.17
1.64
1.22
2.34
2.93
2.65
2.2
2.34
Short-term debt
15.9
22.3
34.2
50.1
0
0
Total current liabilities
76.2
109
157
242
307
371
259
259
180
194
Long-term debt
85.2
70.8
46.1
Lease liabilities
9.44
9.15
8.58
10
8.74
7.72
6.08
Other non-current liabilities
0.71
1.15
10.5
3.75
6.21
7.65
8.21
9.06
11.5
11
Total liabilities
176
227
233
274
339
401
291
280
199
211
Total debt
93.6
92.4
79.7
49.7
0
0
Paid-in capital
965
978
1,283
1,764
1,818
1,855
1,885
1,899
1,915
1,924
Retained earnings
-1,204
-1,272
-1,389
-1,411
-1,429
-1,421
-1,527
-1,586
-1,669
-1,707
Treasury stock
-1.5
-4.23
-10.4
-35.9
-51.1
-60.7
-61.8
-63.8
-65.3
-67.4
Shareholders' equity
-9.06
-65.1
152
608
628
667
595
552
486
459
Total equity
-9.06
-65.1
152
608
628
667
595
552
486
459
Total liabilities and equity
167
162
386
882
966
1,068
886
832
685
671
Shares outstanding
269
271
326
360
393
397
409
409
412
416
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-86.4
-67.9
-116
-22.6
-18
7.73
-106
-59.1
-82.2
-38.8
Depreciation and amortization
0.14
0.06
0.02
0.2
0.6
0.6
0.6
0.2
0.1
Stock-based compensation
13.6
14
18.8
30.9
45.8
36.9
26.2
15.6
17.7
13.9
Deferred income tax
8.8
11.1
Change in receivables
-6.17
-25.3
-21.2
-49.9
-38.1
-9.08
32.7
-2.57
11.3
-4.55
Change in inventory
-1.52
-9.75
-27.5
-19
-112
-167
-36.4
56.1
105
34.9
Cash from operations
-71.8
-32.8
-94.7
-9.37
-21.7
-66.5
-180
6.88
-31
6.73
Capital expenditures
-0.02
-0.01
-0.06
-2.48
-0.25
Purchases of investments
-679
-290
-81.6
-215
-279
-200
Sales and maturities of investments
302
394
258
190
233
209
Cash from investing
-0.02
-0.01
-0.06
-2.48
-377
104
175
-25.5
-46
8.83
Debt repaid
-3.32
-14.7
-31.7
-50.3
Stock issued
64.6
0.64
265
440
5.16
2.92
0.06
1.88
0.01
0
Cash from financing
63.1
8.24
271
410
-58.9
-5.07
-0.38
0.23
-1.44
-2.03
Net change in cash
-8.71
-24.6
176
398
-458
32.5
-5.18
-18.4
-78.4
13.5
Free cash flow
-71.8
-32.8
-94.8
-11.8
-22
Interest paid
17.1
17.2
21.5
4.59
2.04
Income taxes paid
1.46
1.75
0.85
-0.07
-0.21
3.66
-1.78
2.37
3.98
1
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $13.20 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
42.0%
Gross profit / revenue.
Operating margin
-21.9%
Operating income / revenue.
Pre-tax margin
-13.7%
Pre-tax income / revenue.
Net margin
-14.6%
Net income / revenue.
Operating cash flow margin
8.4%
Cash from operations / revenue.
Return on equity (ROE)
-6.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-4.3%
Net income / average total assets.
Return on invested capital (ROIC)
-10.7%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
10.2%
Research and development expense / revenue.
SG&A / revenue
44.6%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
4.3%
Stock-based compensation (from the cash flow statement) / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-6.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-16.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-19.0%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
48.5%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-20.7%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-24.2%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-5.5%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-8.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-6.1%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-2.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-8.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-7.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
1.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
1.1%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
1.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.67x
Current assets / current liabilities.
Quick ratio
2.48x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.92x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.45
Revenue / diluted weighted shares.
Operating cash flow per share
$0.04
Cash from operations / diluted weighted shares.
Book value per share
$1.06
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.50x
Market cap / revenue.
P/B
0.63x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.65x
Market cap / tangible book value, when positive.
P/OCF
17.9x
Market cap / cash from operations, when positive.
Earnings yield
-9.7%
Net income / market cap (the inverse of P/E).
What was AMARIN CORP PLC\UK's revenue in fiscal 2025?
AMARIN CORP PLC\UK reported revenue of $213.6M for fiscal 2025, 6.5% lower than the year before.
Was AMARIN CORP PLC\UK profitable in fiscal 2025?
No. It reported a net loss of $38.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.